Jefferson University Hospitals

Physician Profile

Jay Herman, MD

Jefferson University Physician

Academic Title: Professor
Director Emeritus, Transfusion Medicine

Blood Banking/Transfusion Medicine (Not Accepting New Patients)

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Gibbon Bldg., Ste. 8220
111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 955-8244
Fax: (215) 923-9387

Medical Services

Years in Practice


Board Certifications

  • Blood Banking/Transfusion Medicine
  • Pediatric Hematology-Oncology
  • Pediatrics

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital


Practice limited to Transfusion Medicine


  • Harvard Medical School, Medical School


  • Grady Memorial Hospital


  • University of Virginia Medical Center
  • Johns Hopkins University Hospital


  • Johns Hopkins University Hospital

Recent Publications

Red blood cell transfusion increases the risk of thrombotic events in patients with subarachnoid hemorrhage

Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts

RhIG for the treatment of immune thrombocytopenia: Consensus and controversy (CME)

In Reply

Prevention of D sensitization after mismatched transfusion of blood components: Toward optimal use of RhIG

Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity

Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation

Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation

Acute hypertensive transfusion reactions

Alternative explanation for "muddy plasma" [3]

Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: Case report and review of the literature

Apheresis platelet transfusions: Does ABO matter?

Platelet dosing

Single-donor platelets reduce the risk of septic platelet transfusion reactions.

Severe cutaneous ulceration following treatment with thalidomide for GVHD

Early prediction of poor hematopoietic progenitor cell (HPC) mobilization

Economic consequences of alterations in platelet transfusion dose: Analysis of a prospective, randomized, double-blind trial

Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial

Considerations in the selection of a platelet component: Apheresis versus whole blood-derived

Metabolic consequences in very low birth weight infants transfused with older AS-1-preserved erythrocytes